Skip Navigation

JNCI Journal of the National Cancer Institute 1997 89(19):1423-1428; doi:10.1093/jnci/89.19.1423
© 1997 by Oxford University Press
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ederer, F.
Right arrow Articles by Mandel, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ederer, F.
Right arrow Articles by Mandel, J. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal Of The National Cancer Institute, Vol 89, 1423-1428, Copyright © 1997 by Oxford University Press

ARTICLES

Fecal occult blood screening in the Minnesota study: role of chance detection of lesions

F Ederer, TR Church and JS Mandel
Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, USA. federer@emmes.com

BACKGROUND: In the Minnesota Colon Cancer Control Study, annual fecal occult blood testing reduced mortality from colorectal cancer by at least 33.4%. Some attribute a large part of this reduction to chance detection of cancers by colonoscopies; rehydration of guaiac test slides greatly increased positivity and consequently the number of colonoscopies performed. This study was conducted to determine how much of the reduction resulted from chance detection. METHODS: We used a mathematical model developed by Lang and Ransohoff to estimate the proportion of the 33.4% mortality attainable by chance alone. Applying the model requires the specification of five parameters: duration of follow-up, rate of compliance with fecal occult blood testing, rate of compliance with colonoscopy, positivity rate, and efficacy of colonoscopy in reducing colorectal cancer mortality. We took values for four of the five parameters directly from the Minnesota study. For the fifth parameter, efficacy of colonoscopy, we selected a value of 60%, based on the conclusions of another study. Whereas the Lang-Ransohoff model selects persons for colonoscopy by chance alone, those with bleeding cancers would also be selected by sensitive fecal occult blood testing. We therefore adjusted the result of the Lang-Ransohoff model for this dual detectability. RESULTS: We found that 16%-25% of the reduction in colorectal cancer deaths effected by fecal occult blood testing in the Minnesota study was due to chance detection; the remainder was due to sensitive detection. CONCLUSION: Chance played a minor role in the detection of colorectal cancers by fecal occult blood testing in the Minnesota study.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JAMAHome page
W. C. Taylor
A 71-Year-Old Woman Contemplating a Screening Colonoscopy
JAMA, March 8, 2006; 295(10): 1161 - 1167.
[Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
U. Haug and H. Brenner
A Simulation Model for Colorectal Cancer Screening: Potential of Stool Tests with Various Performance Characteristics Compared with Screening Colonoscopy
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 422 - 428.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. T. Hawk and B. Levin
Colorectal Cancer Prevention
J. Clin. Oncol., January 10, 2005; 23(2): 378 - 391.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
P. M. McMahon, J. L. Bosch, S. Gleason, E. F. Halpern, J. S. Lester, and G. S. Gazelle
Cost-Effectiveness of Colorectal Cancer Screening
Radiology, April 1, 2001; 219(1): 44 - 50.
[Abstract] [Full Text]

Home page
 CA Cancer J ClinHome page
R. A. Smith, A. C. von Eschenbach, R. Wender, B. Levin, T. Byers, D. Rothenberger, D. Brooks, W. Creasman, C. Cohen, C. Runowicz, et al.
American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001--Testing for Early Lung Cancer Detection
CA Cancer J Clin, January 1, 2001; 51(1): 38 - 75.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. S. Mandel, T. R. Church, J. H. Bond, F. Ederer, M. S. Geisser, S. J. Mongin, D. C. Snover, and L. M. Schuman
The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer
N. Engl. J. Med., November 30, 2000; 343(22): 1603 - 1607.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
B. Levin
Colorectal Cancer Screening: Sifting Through the Evidence
J Natl Cancer Inst, March 3, 1999; 91(5): 399 - 400.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J. S. Mandel, T. R. Church, F. Ederer, and J. H. Bond
Colorectal Cancer Mortality: Effectiveness of Biennial Screening for Fecal Occult Blood
J Natl Cancer Inst, March 3, 1999; 91(5): 434 - 437.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. B. Simon, R. H. Fletcher, J. B. Simon, and R. H. Fletcher
Should All People over the Age of 50 Have Regular Fecal Occult-Blood Tests?
N. Engl. J. Med., April 16, 1998; 338(16): 1151 - 1155.
[Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.